AKOYA BIOSCIENCES, INC

Akoya Biosciences, Inc. specializes in the manufacturing, maintenance, and software support of advanced analytical laboratory instruments and in vitro diagnostic reagents, with deep expertise in quantitative imaging systems such as the Phenocycler and Phenocycler HT platforms. The company provides end-to-end solutions including proprietary OPAL multiplexed immunohistochemistry reagents, instrument servicing, software upgrades, and preventive maintenance for precision biomedical equipment. Their technical capabilities center on spatial biology, multiplexed tissue imaging, and integrated bioinformatics workflows, enabling high-plex protein detection in formalin-fixed paraffin-embedded samples. Akoya’s unique differentiator lies in its proprietary fluorescence-based barcoding technology and closed-loop instrumentation-software ecosystems that support reproducible, high-resolution tissue analysis for translational research and clinical diagnostics. The company maintains a strong and consistent relationship with the Department of Veterans Affairs and the Department of Health and Human Services, delivering diagnostic reagents, instrument servicing, and software support critical to veterans’ health research and public health laboratories. Work for these agencies consistently involves sustained operational support for imaging platforms used in cancer, immunology, and infectious disease studies, indicating long-term, mission-critical partnerships. Akoya’s primary industry focus is in in vitro diagnostic substance manufacturing and analytical laboratory instrument manufacturing, positioning them as a niche provider in the spatial biology and multiplexed tissue analysis market. Their work spans diagnostic reagent development, instrument lifecycle support, and bioinformatics software publishing, serving biomedical research, clinical diagnostics, and public health laboratories. Akoya Biosciences, Inc. is a small business headquartered in Marlborough, Massachusetts, with no federal certifications on record. The company operates as a specialized technology supplier to the federal biomedical research and healthcare infrastructure, leveraging its proprietary platforms to serve high-compliance, high-precision government science missions.